419 related articles for article (PubMed ID: 20017725)
1. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
Jaganathan R; Ravindran R; Dhanasekaran S
Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. Focus on adipokines.
Fietta P; Delsante G
Theor Biol Forum; 2013; 106(1-2):103-29. PubMed ID: 24640423
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
6. The new adipose tissue and adipocytokines.
Bulcão C; Ferreira SR; Giuffrida FM; Ribeiro-Filho FF
Curr Diabetes Rev; 2006 Feb; 2(1):19-28. PubMed ID: 18220614
[TBL] [Abstract][Full Text] [Related]
7. Alcohol intake modulates hormonal activity of adipose tissue.
Pravdova E; Fickova M
Endocr Regul; 2006 Sep; 40(3):91-104. PubMed ID: 17100551
[TBL] [Abstract][Full Text] [Related]
8. Adipokines: a link between obesity and cardiovascular disease.
Nakamura K; Fuster JJ; Walsh K
J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
[TBL] [Abstract][Full Text] [Related]
9. Adipokines as drug targets in diabetes and underlying disturbances.
Andrade-Oliveira V; Câmara NO; Moraes-Vieira PM
J Diabetes Res; 2015; 2015():681612. PubMed ID: 25918733
[TBL] [Abstract][Full Text] [Related]
10. Role of adipokines in complications related to obesity: a review.
Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
[TBL] [Abstract][Full Text] [Related]
11. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
12. Role of Adipokines in Cardiovascular Disease.
Lau WB; Ohashi K; Wang Y; Ogawa H; Murohara T; Ma XL; Ouchi N
Circ J; 2017 Jun; 81(7):920-928. PubMed ID: 28603178
[TBL] [Abstract][Full Text] [Related]
13. Endocrine and signalling role of adipose tissue: new perspectives on fat.
Trayhurn P
Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
[TBL] [Abstract][Full Text] [Related]
14. The endocrine function of adipose tissue: an update.
Ronti T; Lupattelli G; Mannarino E
Clin Endocrinol (Oxf); 2006 Apr; 64(4):355-65. PubMed ID: 16584505
[TBL] [Abstract][Full Text] [Related]
15. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
Odrowaz-Sypniewska G
Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
[TBL] [Abstract][Full Text] [Related]
16. Overweight and obesity: the pathogenesis of cardiometabolic risk.
Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
[TBL] [Abstract][Full Text] [Related]
17. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
18. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
[TBL] [Abstract][Full Text] [Related]
19. [Adipose tissue: a new endocrine organ].
Krysiak R; Okopień B; Herman ZS
Przegl Lek; 2005; 62(9):919-23. PubMed ID: 16541730
[TBL] [Abstract][Full Text] [Related]
20. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
